MedTrace Logo

Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion

NCT01266239 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2010-12-24

No results posted yet for this study

Summary

In study-1, the purpose of this study is to compare the long-term outcome of provisional stenting between EES and SES deployment. In study-2, it is to prove the following hypothesis " Asymmetrical expansion in the bifurcation lesion leads to frequent inhomogeneous intimal growth on the strut and thrombus attachment."

Conditions

  • Ischemic Heart Disease

Interventions

PROCEDURE

kissing balloon inflation

Kissing balloon inflation following the MV stenting

DEVICE

EES vs. SES

Rapid endothelialization after EES deployment has been reported compared to that after SES deployment.

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Cordis Corporation

    collaborator INDUSTRY

  • Shin Yukuhashi Hospital

    lead NETWORK

Principal Investigators

  • Yoshinobu Murasato, MD, PhD · New Yukuhashi Hospital

  • Yoshihisa Kinoshita, MD · Toyohashi Heart Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-07-31
Completion
2015-07-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01266239 on ClinicalTrials.gov